[Effectiveness and tolerance of aerosol disodium cromoglycate in children with bronchial asthma].
Thirteen centres studied the efficacy and safety of nebulized cromolyn solution in 53 asthmatic children (36 m., 17 f.; mean age 4.8 +/- 1.7 years). During a fiveweek treatment period a significant reduction of asthmatic symptoms was observed by investigators daily symptom scores, as assessed by the parents, also showed a significant improvement during treatment period. In addition, there was also a marked decrease in the use of other anti-asthmatic medication (beta 2-sympathomimetics, theophylline and antihistamines). There were no side effects of nebulized cromolyn solution treatment.
Zarkovic
J
J
Universitäts-Kinderklinik, Wien.
Angermayr
R
R
Covi
B
B
Danhorn
H
H
Eber
E
E
Emhofer
J
J
Hagel
E
E
Hirschmann
R
R
Klabuschnigg
A
A
Riedler
J
J
D000336:Aerosols; D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004205:Cromolyn Sodium / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009330:Nebulizers and Vaporizers
D000336:Aerosols; D004205:Cromolyn Sodium
Wirksamkeit und Verträglichkeit von vernebeltem Dinatrium Cromoglykat bei Kindern mit Asthma bronchiale.